risperidone has been researched along with Pseudotumor Cerebri in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 17-year-old girl gained more than 25 kg in weight during treatment with risperidone and subsequently developed headache, diplopia and loss of vision due to IIH." | 3.81 | [Idiopathic intracranial hypertension and obesity]. ( Braakman, HM; Naarden, MT; Porro, GL; Schuitemaker, A; Straver, JS; van Doormaal, TP, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naarden, MT | 1 |
| Schuitemaker, A | 1 |
| Braakman, HM | 1 |
| van Doormaal, TP | 1 |
| Porro, GL | 1 |
| Straver, JS | 1 |
| Ahmed, H | 1 |
| Ali, H | 1 |
2 other studies available for risperidone and Pseudotumor Cerebri
| Article | Year |
|---|---|
[Idiopathic intracranial hypertension and obesity].
Topics: Adolescent; Antipsychotic Agents; Female; Headache; Humans; Obesity; Pseudotumor Cerebri; Risperidon | 2015 |
Risperidone induced weight gain leading to benign intracranial hypertension.
Topics: Antipsychotic Agents; Bipolar Disorder; Female; Humans; Obesity, Morbid; Pseudotumor Cerebri; Risper | 2011 |